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Abstract
Cyprinid herpesvirus 3 (CyHV-3) is causing severe economic losses worldwide in common
and koi carp industries, and a safe and efficacious attenuated vaccine compatible with
mass vaccination is needed. We produced single deleted recombinants using prokaryotic
mutagenesis. When producing a recombinant lacking open reading frame 134 (ORF134),
we unexpectedly obtained a clone with additional deletion of ORF56 and ORF57. This triple
deleted recombinant replicated efficiently in vitro and expressed an in vivo safety/efficacy
profile compatible with use as an attenuated vaccine. To determine the role of the double
ORF56-57 deletion in the phenotype and to improve further the quality of the vaccine candi-
date, a series of deleted recombinants was produced and tested in vivo. These experiments
led to the selection of a double deleted recombinant lacking ORF56 and ORF57 as a vac-
cine candidate. The safety and efficacy of this strain were studied using an in vivo biolumi-
nescent imaging system (IVIS), qPCR, and histopathological examination, which
demonstrated that it enters fish via skin infection similar to the wild type strain. However,
compared to the parental wild type strain, the vaccine candidate replicated at lower levels
and spread less efficiently to secondary sites of infection. Transmission experiments allow-
ing water contamination with or without additional physical contact between fish demon-
strated that the vaccine candidate has a reduced ability to spread from vaccinated fish to
naïve sentinel cohabitants. Finally, IVIS analyses demonstrated that the vaccine candidate
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induces a protective mucosal immune response at the portal of entry. Thus, the present
study is the first to report the rational development of a recombinant attenuated vaccine
against CyHV-3 for mass vaccination of carp. We also demonstrated the relevance of the
CyHV-3 carp model for studying alloherpesvirus transmission and mucosal immunity in
teleost skin.
Author Summary
Common carp, and its colorful ornamental variety koi, is one of the most economically
valuable species in aquaculture. Since the late 1990s, the common and koi carp culture in-
dustries have suffered devastating worldwide losses due to cyprinid herpesvirus 3 (CyHV-
3). In the present study, we report the development of an attenuated recombinant vaccine
against CyHV-3. Two genes were deleted from the viral genome, leading to a recombinant
virus that is no longer capable of causing the disease but can be propagated in cell culture
(for vaccine production) and infect fish when added to the water, thereby immunizing the
fish. This attenuated recombinant vaccine also had a drastic defect in spreading from vac-
cinated to non-vaccinated cohabitant fish. The vaccine induced a protective mucosal im-
mune response capable of preventing the entry of virulent CyHV-3 and is compatible with
the simultaneous vaccination of a large number of carp by simply immersing the fish in
water containing the vaccine. This vaccine represents a promising tool for controlling the
most dreadful disease ever encountered by the carp culture industries. In addition, the
present study highlights the importance of the CyHV-3 - carp model for studying alloher-
pesvirus transmission and mucosal immunity in teleost skin.
Introduction
Aquaculture is currently one of the world’s fastest growing food production sectors, with an
annual growth rate of 6.2% between 2000 and 2012 [1]. Global aquaculture currently provides
half of the fish consumed worldwide. However, aquaculture is suffering important economic
losses due to outbreaks of infectious and parasitic diseases [2–4], which are promoted by high
rearing densities under artificial conditions [5], the efficient abiotic vector properties of water
[5], and the international trade of genitors and fingerlings [6].
Inland aquaculture of freshwater finfishes dominates global aquaculture, representing
57.9% (38.6 million tons) of global production of aquaculture, far greater than mollusks
(22.8%), crustaceans (9.7%), and mariculture of finfishes (8.3%) and other aquatic animals
(1.3%) [1]. The common carp (Cyprinus carpio) is one of the oldest cultivated freshwater fish
species. In China, carp cultivation dates back to at least the 5th century BC, and in Europe
carp farming began during the Roman Empire [7]. Common carp is currently one of the most
economically valuable species in aquaculture; it is one of the main fish species cultivated for
human consumption, with worldwide production of 3.8 million tons (the third most important
species based on the number of tons produced) in 2012, representing 9.8% of all freshwater fish
production and US$5.2 billion [8]. Common carp is also produced and stocked in fishing areas
for angling purposes. In addition, its colorful ornamental varieties (koi carp) grown for person-
al pleasure and competitive exhibitions represent one the most expensive markets for individu-
al freshwater fish, with some prize-winners being sold for US$10,000-1,000,000 [9].
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Koi herpesvirus (KHV), also known as cyprinid herpesvirus 3 (CyHV-3; species Cyprinid
herpesvirus 3, genus Cyprinivirus, family Alloherpesviridae, order Herpesvirales), is the etiologi-
cal agent of an emerging and mortal disease in common and koi carp [10]. Since its emergence
in the late 1990s, this highly contagious disease has caused severe economic losses worldwide
in both common and koi carp culture industries [9,11,12]. Outbreaks of CyHV-3 disease are
associated with a mortality rate of 80–100% [9]. As an example, outbreaks of CyHV-3 in Indo-
nesia in 2002 and 2003 caused an estimated economic loss of US$15 million [13,14].
The economic losses caused by infectious and parasitic diseases in aquaculture have moti-
vated the development of efficient prophylactic vaccines [2,3]. In addition to the safety/efficacy
issues that apply to all vaccines independent of the target species (humans or animals), vaccines
for fish and production animals in general are under additional constraints. First, the vaccine
must be compatible with mass vaccination and administered via a single dose as early as possi-
ble in life. Second, the cost-benefit ratio should be as low as possible, implying the lowest cost
for vaccine production and administration [5]. Ideally, cost-effective mass vaccination of
young fish is performed by bath vaccination, meaning that the fish are immersed in water con-
taining the vaccine [15]. This procedure allows vaccination of a large number of subjects when
their individual value is still low and their susceptibility to the disease highest [15]. The use of
injectable vaccines for mass vaccination of fish is restricted to limited circumstances, i.e. when
the value of an individual subject is relatively high and when vaccination can be delayed until
an age when the size of the fish is compatible with their manipulation [16,17].
Various anti-CyHV-3 vaccine candidates have been developed [18–27]. Injectable DNA
vaccines are efficacious under experimental conditions [21,22] but incompatible with most of
the field constraints described above (i.e., the value of an individual common carp is very low
and they should be vaccinated when only a few grams). In contrast, attenuated vaccines could
meet these constraints but raise safety concerns, such as residual virulence, reversion to
virulence, and spreading from vaccinated to naïve subjects. A conventional anti-CyHV-3 atten-
uated vaccine has been developed by serial passages in cell culture and UV irradiation
[18–20,26,27]. This vaccine is commercialized in Israel by the KoVax Company for the vacci-
nation of koi and common carp by immersion in water containing the attenuated strain and
was recently launched in the US market under the name Cavoy but was withdrawn from sale
after just a year. This vaccine has two major disadvantages. First, the attenuated strain has re-
sidual virulence for fish weighing less than 50 g [18,27]. Second, the determinism of the attenu-
ation is unknown, and consequently, reversions to a pathogenic phenotype cannot be excluded
[28].
Due to scientific advances in molecular biology and molecular virology, the development of
attenuated vaccines is evolving from empirical to rational design [28–30]. A viral genome can
be edited to delete genes encoding virulence factors in such a way that reversion to virulence
can be excluded. This approach has been tested for CyHV-3 by targeting different genes
thought to encode virulence factors, such as open reading frame (ORF) 16, ORF55, ORF123,
and ORF134, which encode a G protein-coupled receptor, thymidine kinase (TK), deoxyuri-
dine triphosphatase, and an Interleukine-10 (IL-10) homolog, respectively. Unfortunately,
none of the recombinants lacking these genes express a safety/efficacy profile compatible with
use as an attenuated recombinant vaccine [23,24,31].
In the present study, we took advantage of a recombinant strain that was obtained by acci-
dent. This strain was deleted of three genes and expressed a safety/efficacy profile compatible
with use as an attenuated vaccine. Using prokaryotic recombination technologies, a series of re-
combinants was produced to identify the determinism of the attenuation and to improve fur-
ther some properties of the vaccine candidate. Based on the results, a double deleted strain was
selected as a vaccine candidate. The safety and efficacy of this strain as a recombinant
Attenuated Recombinant Cyprinid Herpesvirus 3 Vaccine
PLOS Pathogens | DOI:10.1371/journal.ppat.1004690 February 20, 2015 3 / 27
attenuated vaccine against CyHV-3 were investigated using various approaches, including an
in vivo bioluminescent imaging system (IVIS). Taken together, the results of the present study
demonstrate that this vaccine candidate is appropriate for safe and efficacious mass vaccination
of carp against CyHV-3, inducing a protective mucosal immune response at the portal of
entry. In addition to its importance for applied research, the present study is also important for
fundamental research by demonstrating the potential of the CyHV-3 - carp model for studying
the transmission of members of the familly Alloherpesviridae and mucosal immunity in teleost
skin.
Results
Determinism of the attenuated phenotype observed for a triple deleted
CyHV-3 strain
In an earlier study, we produced a CyHV-3 recombinant strain lacking ORF134, which encodes
a viral IL-10 [31]. This recombinant was produced using a bacterial artificial chromosome
(BAC) clone of the CyHV-3 FL strain and prokaryotic recombination technologies. To recon-
stitute infectious viral particles encoding a wild-type ORF55 locus (encoding TK) in which the
BAC cassette was inserted, the FL BAC ORF134 Del galactokinase (galK) plasmid (deleted for
ORF134) was co-transfected with the pGEMT-TK plasmid in permissive Cyprinus carpio brain
(CCB) cells. For one of the viral clones we obtained, this procedure led to unexpected non-ho-
mologous recombination between the pGEMT vector and the beginning of ORF57, leading to
reversion to a wild-type ORF55 locus and deletion of CyHV-3 genome from coordinates 97001
to 99726. This deleted region encodes most of ORF56 and the beginning of ORF57 (Fig. 1A).
Despite this triple deletion (ORF56-57 and ORF134), this strain replicated efficiently in vitro,
reaching a titer of 106 plaque forming units (pfu)/ml. Moreover, it expressed in vivo a safety/ef-
ficacy profile compatible with use as an attenuated vaccine for vaccination of carp against
CyHV-3 by immersion in water containing the virus.
Here, we produced and tested a series of recombinant strains to establish the contribution
of the ORF134 and the ORF56-57 deletions to the observed safety/efficacy profile of the triple
deleted recombinant described above. Based on our recent study demonstrating that ORF134
is not essential for virulence in vivo [31], we hypothesized that the attenuated phenotype of the
triple deleted strain was mainly, if not exclusively, determined by the ORF56-57 deletion. How-
ever, deletion of ORF134, which encodes an IL-10 homolog, could potentially contribute to the
safety observed for the triple recombinant and/or the immune response it induced. To test
these hypotheses, two groups of recombinants were produced independently using BAC clon-
ing technologies according to the strategy described in Fig. 1B. Both groups encoded the
ORF56-57 deletion (Fig. 1A) encompassing coordinates 97001 to 99750. This deletion was
slightly longer on the 3’ end than the deletion observed in the triple deleted strain described
above in order to remove two potential alternative ATG start codons present in the beginning
of ORF57. In addition to the ORF56-57 deletion, one of the groups also encoded an ORF134
deletion. When reconstituting infectious virions from recombinant BAC plasmids, the BAC
cassette was removed by homologous recombination, leading to a wild-type ORF55 locus, or
by cre-loxP-mediated excision, leading to a truncated ORF55 locus (TKtrunc genotype). The
molecular structures of all recombinant strains were controlled by SacI restriction fragment
length polymorphism (RFLP), Southern blot analysis (S1 Fig.), and sequencing of the genome
region encoding ORF55 to ORF57. Strains encoding wild-type loci had a sequence identical to
the reference sequence available in the GenBank (Accession number NC_009127.1) and all re-
combinant strains had the expected modified sequences. All recombinants were tested for their
virulence (i.e., safety) and their ability to induce immune protection against a lethal challenge
Attenuated Recombinant Cyprinid Herpesvirus 3 Vaccine
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Fig 1. Production of CyHV-3 recombinants. (A) Schematic representation of wild-type ORF56-57 and ORF56-57 deleted genotypes. CyHV-3 ORFs are
represented by white arrows. Predicted promoters in the ORF56-ORF57 region are represented by angular black arrows below the wild-type ORF56-57
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(i.e., efficacy) (Figs. 2 and S2). Independent of the ORF55 genotype (wild-type versus truncated
(TKtrunc)) and ORF134 genotype (wild-type versus deleted (Δ134)), all recombinants encod-
ing the double ORF56-57 deletion (Δ56-57) expressed comparable safety/efficacy profiles. Fish
infected with the WT (Fig. 2) or the TKtrunc (S2 Fig.) strains exhibited all clinical signs
genotype. In-frame ATGs of ORF57 are indicated by red lines. SacI restriction sites and predicted restriction fragments (in kb) are shown. Coordinates are
those of the CyHV-3 reference strain available in GenBank (Accession number NC_009127.1). (B) Flowchart of the production of double (Δ56-57) and triple
(Δ56-57Δ134) deleted recombinants for CyHV-3 ORF134 and/or ORF56-57. To simplify the reading of the manuscript, recombinants were given a nickname
(in red) that will be used hereafter. The right side of the figure summarizes the genotype of the strains for ORF55 (TK), ORF56-57, and ORF134. Del, deleted;
trunc, truncated.
doi:10.1371/journal.ppat.1004690.g001
Fig 2. Safety-efficacy profile of doubleΔ56-57 and tripleΔ56-57Δ134 deleted recombinants encoding a wild-type TK locus. The safety and efficacy
of the indicated recombinant strains was tested in common carp (average weight 3.77 g ± 1.95 g, 7 months old). On day 0, fish were infected for 2 h by
immersion in water containing 4 (□), 40 (), or 400 (x) pfu/ml. Safety was investigated by measuring the survival rate for 21 days in a group of 30 carp. Efficacy
was tested at 21 and 42 dppi. Mock-infected fish and fish that survived the primary infection were distributed in tanks (n = 15) and challenged by cohabitation
with fish infected with the FL strain.
doi:10.1371/journal.ppat.1004690.g002
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associated with CyHV-3 disease, including apathy, folding of the dorsal fin, hyperemia, in-
creased mucus secretion, skin lesions, suffocation, erratic swimming, and loss of equilibrium.
Independent of the dose tested, mortality ranged from 47 to 87%. In contrast, all double
ORF56-57 deleted (Δ56-57) strains expressed an attenuated phenotype. No clinical signs were
observed in fish inoculated at 4 or 40 pfu/ml, and only a few fish expressed transient mild hy-
peremia and folding of the dorsal fin at the higher dose (400 pfu/ml). Importantly, all fish ex-
hibited unaltered swimming and feeding behavior. These observations were confirmed by the
survival rate, which was very high in all groups (a single fish died in the group inoculated with
the highest dose of the Δ56-57Δ134 strain). To investigate if the fish initially inoculated with
strains encoding the ORF56-57 deletion developed a protective anti-CyHV-3 immune re-
sponse, they were challenged at 21 and 42 days post-primary infection (dppi) by cohabitation
with fish that were freshly inoculated with the parental FL strain (Fig. 2 and S2 Fig.). Though
mock-infected fish were very sensitive to this challenge (reaching 100% mortality rate in nearly
all cases), fish previously infected with strains encoding the ORF56-57 deletion at 400 pfu/ml
did not express the disease and had a survival rate of 100%. Fish initially inoculated at 40 pfu/
ml exhibited also very high survival rates (100% or 93%). Fish initially inoculated at 4 pfu/ml
exhibited partial protection ranging from 27% to 80% survival rate. Interestingly, the challenges
performed 21 dppi led to comparable results 42 dppi, indicating early onset of protective im-
munity. The results presented above demonstrate that the double ORF56-57 deletion correlat-
ed with a safety/efficacy profile compatible with use of the encoding strain as an attenuated
vaccine. Additional truncation of ORF55 and/or deletion of ORF134 did not improve the safe-
ty/efficacy profile. The latter result is consistent with our recent study demonstrating that
ORF134 does not affect CyHV-3 virulence [31] as observed for other virally encoded IL-10 ho-
mologs [32].
Taking into account the results for safety and efficacy, as well as the stability of the ORF56-
57 deletion observed when the virus was passed extensively in cell culture (demonstrated by se-
quencing of both ORFs after passage of the virus under industrial conditions corresponding to
vaccine production, Master Seed Virus +5; sequences observed were identical to initially edited
sequences), the Δ56-57 strain was selected as an attenuated recombinant vaccine candidate
against CyHV-3 disease.
Safety of the Δ56-57 strain studied by the IVIS
Recently, we demonstrated the usefulness of the IVIS to study the portal of entry and spreading
of CyHV-3 into its host [33–36]. In the present study, we exploited this technology to investi-
gate the safety of the Δ56-57 strain. To achieve this goal, a recombinant strain encoding both
the ORF56-57 deletion and a luciferase (Luc) expression cassette inserted in a previously stud-
ied insertion site [33], hereafter called the Δ56-57 Luc strain, was produced by homologous re-
combination in eukaryotic cells (S3 Fig.). The molecular structure of this strain was confirmed
by RFLP, Southern blot analysis (S4 Fig.), and full-length genome sequencing. Full length ge-
nome sequence of WT Luc and Δ56-57 Luc strains have been deposited in the GenBank (Ac-
cession numbers KP343683 and KP343684, respectively). The two strains share a number of
defects in genes other than those noted in other strains. This includes one point deletion in
ORF129 (GGGG>GGG), one inversion/deletion in ORF122, one deletion affecting the ends of
ORF27 (already mutated in some other CyHV-3 strains) and ORF28. However, since these
mutations are present in both WT Luc and Δ56-57 Luc strains, they are not relevant to the at-
tenuated observed phenotype.
Before its use in vivo, the Δ56-57 Luc strain was tested in vitro. First, even if the insertion of
the Luc expression cassette in a wild type strain was previously shown to have no effect on viral
Attenuated Recombinant Cyprinid Herpesvirus 3 Vaccine
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growth in cell culture and virulence in vivo [33], we tested whether this insertion affects viral
growth for the Δ56-57 genotype (Fig. 3A). Replication of the Δ56-57 Luc strain was comparable
to that of the Δ56-57 strain. Consistent with an earlier report [33], replication of the WT Luc
strain was comparable to that of the WT strain. These data demonstrate that insertion of the
Luc cassette between ORF136 and ORF137 had no effect on viral growth. However, this experi-
ment revealed that both strains encoding the ORF56-57 deletion replicated at a significantly
lower level than the strains encoding the ORF56-57 wild-type genotype (p<0.0001 at 2 and 4
Fig 3. Effect of the double ORF56-57 deletion on CyHV-3 replication in vitro. (A) Multi-step growth
curves. CCB cells were infected with the indicated strains and the viral titer (pfu/ml) in the cell supernatant
determined at the indicated time points post-infection. Data presented are the mean ± SD of triplicate
measurements. Significant differences between the two ORF56-57 wild-type strains (WT andWT Luc) and
the two double ORF56–57 deleted strains (Δ56-57 and Δ56-57 Luc) were tested using three-way ANOVA
taking ORF56–57 genotype (wild-type vs. deleted), presence or absence of Luc, and time post-infection as
variables. The p-values demonstrated a significant effect of ORF56-57 genotype independent of the Luc
genotype. (B) Luc activity. CCB cells were infected with the indicated strains at the indicated MOI. Luc
expression was analyzed by the IVIS at different times post-infection. Data presented are the radiance ± SD
of quadruplicate analyses. Significant differences were tested using three-way ANOVA taking viral strain,
MOI, and time post-infection as variables. The p-values demonstrated a significant effect of the viral strain
independent of the MOI. The raw data of these experiments (panels A and B) are provided online (S1
Dataset).
doi:10.1371/journal.ppat.1004690.g003
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days post-infection (dpi), and p = 0.0012 at 6 dpi). Second, to investigate whether the ORF56-
57 deletion affects the expression of the Luc expression cassette, CCB cells were infected at
different multiplicity of infection (MOI) with the WT Luc strain and Δ56-57 Luc strain
(Fig. 3B). IVIS analyses performed 12 and 24 hours post-infection (hpi) demonstrated that the
transduced Luc expression was comparable between the two strains. In contrast, analyses per-
formed 48 hpi revealed significantly faster replication of the WT Luc strain compared to the
Δ56-57 Luc strain (p<0.0001). Taken together, the results demonstrate that Δ56-57 Luc strain
replication in vitro is comparable to that of the Δ56-57 strain, and it transduces Luc expression
comparably to the WT Luc strain. These data validate the use of these two Luc recombinant
strains to investigate the effect of the double ORF56-57 deletion on the pathogenesis of CyHV-
3. This question was investigated by performing the experiment described in Fig. 4.
Fig 4. Flow chart of experiments performed to study the effect of the double ORF56-57 deletion on
CyHV-3 pathogenesis. At time 0, carp (mean weight ± SD 30.40 g ± 9.12 g, 9 months old) were infected for
2 h by immersion in water containing WT Luc strain or the Δ56-57 Luc strain at 400 pfu/ml, then returned to
larger tanks. At the indicated time points (restricted to maximum 8 dpi for the WT Luc strain to precede the
peak of mortality), fish were sampled and submitted to the read-outs listed in the lower part of the figure. The
read-out data are presented in Figs. 5–7. Throughout these figures, the data obtained for each fish (according
to viral strain and time post-infection) are represented by the same symbol to allow correlation of the data
obtained for the different organs and with the different read-outs.
doi:10.1371/journal.ppat.1004690.g004
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Fig 5. Effect of the double ORF56-57 deletion on viral tropism according to the IVIS. The graphs present the average radiance emitted (p/sec/cm2/sr)
per fish and per indicated organ according to time post-infection (mean + SD is represented for each time point). The average radiance was measured over a
region of interest manually drawn following the outline of dissected organs. For the skin, the average radiance (individual values, mean + SD) was measured
on both sides of the body, and the results for individual fish are expressed as the mean of both sides. The discontinuous line represents the cut-off for
positivity and represents the mean + 3 SD (p< 0.00135) of the values obtained (not represented) for mock-infected fish (negative control). The number of
positive fish among six analyzed fish is represented by grey bars. Statistical analyses compared the first four time points (2, 4, 6, and 8 dpi) available for both
strains. The p-value and level of significance are indicated. The average emitted radiances were compared using a two-way ANOVA taking viral strain and
time post-infection as variables (p(rad)), whereas the number of positive fish per group was compared using a permutation test (p(no)).
doi:10.1371/journal.ppat.1004690.g005
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Fish were inoculated by immersion in water containing the WT Luc strain or Δ56-57 Luc
strain. At different times post-infection (restricted to 8 dpi for the WT Luc strain to precede
the peak of mortality), fish were collected and each fish analyzed by the IVIS (Fig. 5), qPCR
(Fig. 6), and histopathological examination (Fig. 7). The results of these read-outs were
presented throughout the figures using a distinctive constant symbol for each analyzed fish ac-
cording to the viral strain inoculated and the time post-infection at which the fish was collect-
ed. This mode of presentation allows identification of all results obtained for a particular fish in
the figures. The skin has been shown to be the major portal of entry of CyHV-3 after inocula-
tion by immersion in water containing the virus [33]. Consistent with this earlier report, we ob-
served that, independent of the inoculated virus, all tested fish expressed light foci on their skin
as early as 2 dpi (Fig. 5). Though the signal increased in intensity from 2 to 6 dpi on fish inocu-
lated with the WT Luc strain, it remained stable for 12 dpi on fish inoculated with the Δ56-57
Luc strain. Global statistical analysis of the data obtained during the first 8 dpi demonstrated
no significant difference in the number of positive fish between the two virus strains, as all fish
were positive, but significantly less light emission was observed for fish infected with the double
ORF56-57 deleted recombinant. After initial replication in the skin, the WT Luc strain spread
and replicated rapidly in all tested organs, and all fish were positive in all organs at 6 dpi
(Fig. 5). These results are consistent with earlier reports [33,34]. Spreading of the Δ56-57 Luc
strain within infected fish was significantly delayed, reduced both quantitatively (i.e., number
of positive fish) and qualitatively (i.e., intensity of the signal), and transient (Fig. 5, compare
left and right columns). The reduced ability of the Δ56-57 Luc strain to spread into infected
fish was further supported by qPCR analysis performed on the gills and heart (Fig. 6).
Fig 6. Effect of the double ORF56-57 deletion on viral tropism according to qPCR analysis. The
number of viral genome copies is expressed as log10 per 10
6 carp glucokinase gene copies. Individual values
represent the mean of duplicate measurements. Mock-infected fish were used as a negative control and no
viral genome copies were detected in these fish. The number of positive fish among six analyzed fish is
represented by grey bars. Statistical analyses compared the first four time points (2, 4, 6, and 8 dpi) available
for both strains. Viral charge (Viral genome copies/106 carp glucokinase gene copies (log10)) was compared
using two-way ANOVA taking viral strain and time post-infection as variables (p(cop)), whereas the number of
positive fish per group was compared using a permutation test (p(no)).
doi:10.1371/journal.ppat.1004690.g006
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Compared to fish infected with the WT Luc strain, fish infected with the double ORF56-57 de-
leted variant expressed significantly lower viral loads. Taken together, the results in Fig. 5 and 6
demonstrate that the Δ56-57 Luc strain was as capable of entering fish as the wild-type control
Fig 7. Effect of the double ORF56-57 deletion on viral pathogenesis based on histopathological analysis of gills. (A) Grading used to characterize the
lesions observed on gill rakers and gill lamellae. Scale bars = 100 μm. (B) Histological preparations were observed by three independent observers. The
grade selected by at least two of the three observers was retained as the final score. The data represent the mean grade + SD for each group at each time
point. Statistical analyses compared the first four time points (2, 4, 6, and 8 dpi) available for both strains. The p-value and level of significance are indicated.
Two types of statistical analyses were performed using permutation tests: comparison of the severity of the lesions (p(gr)) and comparison of the number of
positive fish (p(no)) according to the viral strain.
doi:10.1371/journal.ppat.1004690.g007
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strain, but it had a reduced ability to spread in the infected animal, thereby explaining its atten-
uated phenotype. Finally, as the gills have been shown to support drastic anatomopathological
modifications during CyHV-3 disease, they were examined at different times post-infection
with the two viral strains (Fig. 7). Examination of both gill rakers and gill lamellae led to the
conclusion that the Δ56-57 Luc strain induced much less severe lesions than the WT Luc strain,
as demonstrated by the significantly fewer positive fish (gill lamellae but not gill rakers) and
significantly lower lesion scores (gill lamellae and gill rakers). These results support the attenu-
ation conferred by the double ORF56-57 deletion and justify the selection of the Δ56-57 strain
as a recombinant attenuated vaccine candidate for mass vaccination of carp by immersion in
water containing the vaccine.
A key safety aspect of an attenuated recombinant vaccine is the possible spread from vacci-
nated to unvaccinated naïve cohabitant subjects. This aspect is particularly important for vacci-
nation in aquaculture, where water can act as an efficient abiotic vector. To address this issue,
we used the two recombinant Luc strains described above to investigate the effect of the double
ORF56-57 deletion on the ability of CyHV-3 to spread from newly infected fish to naïve senti-
nel fish (Fig. 8). The spread of CyHV-3 was studied using two experimental settings designed
to allow transmission of the virus through infectious water (water sharing) or through infec-
tious water and physical contact between infected and naïve sentinel fish (tank sharing). Fish
were infected with either the WT Luc strain or the Δ56-57 Luc strain for 2 h in water contain-
ing the virus. After rinsing in fresh water, infected fish were distributed in tanks (Fig. 8) for
water sharing and tank sharing experiments. The IVIS analysis of initially infected fish 2 dpi
(n = 4 for each virus strain) demonstrated that they all expressed luciferase activity on their
skin as described in Fig. 5 (2 days post-infection, skin analysis), thereby demonstrating success-
ful infection. The IVIS analysis of sentinel fish was performed after different periods of cohab-
itation to investigate potential spreading; the experiment was stopped at day 14 for the WT Luc
strain because the vast majority of fish were dying from the infection. Under water sharing con-
ditions, no transmission was detected for the Δ56-57 Luc strain over 18 days. In contrast, for
the WT Luc strain, positive fish (2 out of 5) were detected as early as 6 days of cohabitation.
Both the number and radiance of positive fish increased with time. Under tank sharing condi-
tions, erratic and rare transmission was observed for the Δ56-57 Luc strain. Only two of the 25
analyzed fish were positive respectively after 10 and 18 days of cohabitation. In contrast, naïve
sentinel fish cohabiting with fish infected with the WT Luc strain became infected as early as 6
days of cohabitation. Taken together, the results demonstrate that the double ORF56-57 dele-
tion drastically impaired the ability of CyHV-3 to spread from freshly infected fish to naïve
sentinel fish.
Efficacy of the Δ56-57 strain studied by the IVIS
The experiments presented above demonstrate the usefulness of the IVIS for studying the safety
of an attenuated recombinant vaccine candidate. In the last section of this study, we also used
the IVIS to characterize the immune protection conferred by the Δ56-57 strain (Fig. 9). Fish
were vaccinated by immersion in water containing two different doses of the Δ56-57 strain. Six
weeks post-primary infection, fish were challenged with theWT Luc strain and analyzed by the
IVIS at 2, 4, and 8 days post-challenge. Analyses performed on day 2 post-challenge revealed few
vaccinated fish (2 fish vaccinated at 40 pfu/ml and 1 fish vaccinated at 400 pfu/ml) expressing a
low luciferase signal close to the threshold determined for the mock-infected/mock-challenged
group. None of the fish analyzed on day 2 post-challenge expressed a positive signal in internal
organs. No positive signal was observed on the skin or internal organs of vaccinated fish at later
time points, independent of the dose used for vaccination. In contrast, mock-infected fish
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challenged with theWT Luc strain expressed increasing light intensity according to time post-in-
fection. The data demonstrate that vaccination with the Δ56-57 strain induces a protective mu-
cosal immune response at the portal of entry.
Fig 8. Effect of the double ORF56-57 deletion on CyHV-3 spread from infected fish to naïve fish. This experiment was performed using a group of
common carp (mean weight ± SD 7.09 g ± 2.38 g, 9 months old). At time 0, some fish were infected (represented by black fish) by immersion for 2 h in water
containing theWT Luc strain or the Δ56-57 Luc strain at 400 pfu/ml. At the end of the inoculation period, infected fish were collected, marked by cutting a
fragment of the superior lobe of the caudal fin, and rinsed twice in water before distribution into two types of 60 L tanks (n = 12 per tank). The two types of
tanks were designed to study virus transmission through only the water (left, water sharing) or through the water and direct fish-to-fish contact (right, tank
sharing). Naive fish (represented by white fish; n = 30 per tank) were distributed to the tanks as illustrated. At the indicated time points post-infection, five
naïve fish were collected from each of the four tanks (2 viral strains × 2 tank conditions) and analyzed by IVIS for Luc expression on the skin. The
discontinuous line represents the cut-off for positivity (p< 0.00135) determined based on the analysis of mock-infected fish. Data represent the analysis of
individual fish. Positive scores are presented in red. The mean radiance + SD is presented for each time point. Statistical analyses compared the number of
positive fish at the first four time points (2, 4, 6, and 8 dpi) available for both strains using a permutation test. The p-value and level of significance
are indicated.
doi:10.1371/journal.ppat.1004690.g008
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Fig 9. Immune protection conferred by the Δ56-57 strain revealed by the IVIS. Common carp (mean ± SD weight 13.82 ± 5.00 g, 9 months old) were
infected for 2 h by immersion in water containing 40 or 400 pfu/ml of the Δ56–57 strain or mock-infected. None of the fish died from primary infection. Forty-
two dppi, fish were challenged by immersion for 2 h in water containing 200 pfu/ml of theWT Luc strain. At the indicated time post-challenge, fish (n = 6) were
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Discussion
In the present study, we took advantage of an accidentally obtained recombinant CyHV-3
strain that exhibited a safety/efficacy profile compatible with use as an attenuated vaccine. This
recombinant strain had deletions at three loci (ORF56-57, and ORF134). To determine the role
of the double ORF56–57 deletion in the phenotype and to improve further the quality of the
vaccine candidate, a series of deleted recombinants was produced and tested in vivo. The Δ56-
57 strain with a deletion encompassing ORF56 and ORF57 was selected and characterized as
an attenuated recombinant vaccine candidate against CyHV-3. This strain exhibited properties
compatible with use as an attenuated recombinant vaccine for mass vaccination of carp by im-
mersion in water containing the virus. It replicated efficiently in vitro, though at a lower level
than the parental wild-type strain, expressed a safe attenuated phenotype, and induced a pro-
tective mucosal immune response against a lethal challenge by blocking viral infection at the
portal of entry.
Deletion of ORF56 and/or ORF57 has not been reported previously for CyHV-3. Sequenc-
ing of the Cavoy attenuated anti-CyHV-3 vaccine demonstrated that it encodes a wild-type
ORF56 and ORF57 sequence identical to the reference sequence available in the GenBank (Ac-
cession number NC_009127.1, sequencing from coordinates 96370 to 101248), whereas immu-
nofluorescent staining of infected cells demonstrated the expression of both proteins (S5 Fig.).
The proteins pORF56 and pORF57 have unknown functions. They both lack a signal peptide
and transmembrane domain. Though pORF57 is one of the most abundant proteins of the
CyHV-3 virion, pORF56 is a non-structural protein [37,38]. Extensive bioinformatic analyses
did not generate a hypothesis concerning their putative functions. Homologs of CyHV-3
ORF56 and ORF57 are found in orthologous positions in the two other cyprinid herpesviruses
(CyHV-1 and CyHV-2) [39], among which CyHV-2 (also known as goldfish hematopoietic
necrosis virus) is responsible for a severe disease initially reported in goldfish (Carassius aura-
tus auratus) that recently emerged in gibel carp (Carassius auratus gibelio) [40]. Based on the
positional orthology of ORF56 and ORF57 in cyprinid herpesviruses, the ORF56-57 deletion
reported here for CyHV-3 can likely be exploited to produce attenuated CyHV-1 and CyHV-2
recombinant vaccine candidates. Homologs of CyHV-3 ORF57 are also present in the cyprini-
virus anguillid herpesvirus 1 (AngHV-1) [41] and a more distantly related virus, crocodilepox
virus (CRV) [39,42], which suggests an ancestral origin for the gene. AngHV-1 infects Europe-
an and Japanese eel (Anguilla anguilla and Anguilla japonica) and is responsible for mortalities
of up to 30% in cultured and wild eel populations [43]. As part of a follow-up project of the
present study, ORF56 and ORF57 single deleted recombinants were produced and were tested
in vivo. The data obtained demonstrate that most of the attenuation observed for the double
deletion ORF56-57 relied on the deletion of ORF57. These data identify the ORF57 homologue
encoded by AngHV-1 (ORF35) as an obvious locus for production of an attenuated recombi-
nant vaccine candidate.
Our earlier finding based on a wild-type CyHV-3 strain suggested that the skin is the major
portal of entry after inoculation by immersion in water containing the virus [33]. After initial
replication in the skin, wild-type CyHV-3 spread rapidly to virtually all organs (Fig. 5, left col-
umn). Soon after the skin, the gills, followed by other organs, support viral infection [34,44,45].
analyzed using the IVIS. (A) Representative images. Images within the blue frame were normalized using the same scale. (B) Average radiance (individual
values, mean + SD) measured on the entire body surface of the fish (individual values represent the mean of the left and right sides obtained for each fish).
The discontinuous line represents the cut-off for positivity, which is the mean + 3 SD (p< 0.00135) of the values obtained (not presented) for mock-infected
and mock–challenged fish (negative control). Positive fish are represented by red filled dots. Significant differences in the mean of the average radiance were
identified by post-hoc t-test after two-way ANOVA analysis taking the treatment and the time post-challenge as variables.
doi:10.1371/journal.ppat.1004690.g009
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Even if the skin was always the first organ to express luciferase, the early positivity of the gills
led to the hypothesis that they could represent an alternative and possibly parallel portal of
entry for the virus [45–47]. The present study of the tropism of the Δ56-57 strain demonstrated
that it also spreads from the skin to all tested organs. However, compared to the wild-type
strain, its systemic spread to the other organs was much slower, and its replication was reduced
in intensity and duration (Figs. 5 and 6). The slower spread of the Δ56-57 vaccine strain within
infected fish allowed better discrimination of the portal(s) of entry from secondary sites of in-
fection. Though the skin of all fish was positive as early as 2 dpi, all of the other tested organs
(including gills and gut) were positive in the majority of fish after 6 dpi. These data further
demonstrate that the skin is the major portal of entry of CyHV-3 after infection by immer-
sion and suggest that the other organs (including gills and gut) represent secondary sites of
replication.
The double ORF56-57 deletion reduced the ability of the virus to spread within infected fish
and impaired virus transmission from infected fish to naïve sentinel fish. In the present study,
we designed two tank systems to test the ability of CyHV-3 strains to spread from infected to
naïve sentinel subjects through indirect or indirect-and-direct contact (Fig. 8). The absence of
detectable transmission under water sharing conditions and the very low level of transmission
detected under tank sharing conditions suggested that fish inoculated with the vaccine candi-
date strain excrete very low amounts of infectious particles during the 18 days following vacci-
nation. Combined with the observation that all vaccinated fish supported skin infection during
the first 8 dpi, these data demonstrate that the ORF56-57 deletion drastically impaired viral ex-
cretion by infected subjects. Notably, the spread of the vaccine candidate strain was tested in
the present study by cohabitation of fish immediately after vaccination. This is in contrast to
previous studies that tested spreading by starting cohabitation weeks after vaccination, when
replication of the attenuated vaccine strain was ending [27].
In addition to its relevance for applied research, the CyHV-3 - carp model has numerous
qualities as a subject of fundamental research [9,11,12]. First, it is phylogenetically distant from
the vast majority of herpesviruses studied so far, thereby providing an original field of research
[10,39,48]. Second, it can be studied in laboratories by infection of its natural host (homologous
virus-host model). Third, it allows the study of the complete infectious cycle of an alloherpes-
virus, including transmission from infected to naïve animals. Transmission is an essential step
in the biological cycle of pathogens and acts as a main motor of their evolution. However, very
few laboratory models currently studied among members of the Herpesvirales allow the study
of transmission [49]. Here, we report two systems allowing the study of CyHV-3 transmission
by indirect or direct contact between infected and naïve sentinel fish. They will be useful for
understanding the biology of an alloherpesvirus and for evaluating the ability of prophylactic
strategies to inhibit the spread of wild-type strains in a fish population. The difference in trans-
mission kinetic observed between the two systems demonstrated that direct contact between
subjects promotes transmission of CyHV-3. Early replication of the virus at the portal of entry
should contribute not only to the spread of the virus in infected fish, but also to the spread of
the virus in the fish population. As early as 2 to 3 dpi, infected fish rubbed themselves against
each other or objects. This behavior could contribute to skin-to-skin transmission [35]. Later
during infection, transmission could also occur when uninfected fish peck macroscopic skin
herpetic lesions developed by infected fish, thereby being infected by both skin to skin contact
and infection of the pharyngeal periodontal mucosa [34]. These data highlight the importance
of inducing a mucosal immune response through vaccination against CyHV-3.
Immunization of carp by immersion in water containing the vaccine candidate strain in-
duced protective mucosal immunity, preventing replication of a challenging strain. Vaccina-
tion by immersion has several advantages. Firstly, it is compatible with mass vaccination.
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Secondly, in contrast to injection based vaccination, it is not restricted by a minimum fish size.
Though the experiments reported in the present study were performed with fish older than 6
months, the safety and the efficacy of the Δ56-57 strain has been demonstrated in younger fish
(4 months old fish, mean weight of 1.3 g). These data demonstrated that the Δ56-57 strain is
compatible with vaccination of carp soon after they acquired a competent adaptive immune
system (at the end of the second month of life [50,51]). Thirdly, in contrast to the oral route,
which favors the greediest fish, vaccination by immersion delivers a comparable dose to each
fish. Finally, it induces antigen exposition and, hopefully, an adaptive immune response at the
portal of entry used by the pathogen. The data presented in Fig. 9 demonstrate that the adap-
tive immune response induced by the vaccine candidate prevented infection of a challenging
strain at the portal of entry. The mucosal immunity induced against CyHV-3 at the portal of
entry could contribute not only to protecting vaccinated fish from CyHV-3 disease (clinical
protection), but also to preventing them from transmitting virulent circulating strains (sterile
immunity), thereby inducing herd immunity. This hypothesis is currently being tested using
the two tank systems described above. The skin of teleost fish is a pluristratified epithelium
composed exclusively of living cells covered by a mucus layer [35]. The large surface area of
this mucosa, combined with its easy access, promoted the study of its innate and adaptive im-
mune components. Interest in teleost skin as a model for studying comparative mucosal immu-
nity recently increased with the discovery of a new immunoglobulin isotype, IgT (or IgZ) [52–
54], specialized in mucosal immunity [55–58]. This specific mucosal adaptive immune re-
sponse further supports the importance of antigen presentation at the pathogen’s portal of
entry to induce topologically adequate immune protection capable of blocking pathogen entry
into the host [59,60]. Future studies are required to unravel the mechanisms underlying the
mucosal immune protection conferred by the anti-CyHV-3 vaccine candidate developed in the
present study. However, this study provides an original model for studying epidermal mucosal
immunity against an infectious agent in teleosts.
Since it was first described in the late 1990s, CyHV-3 rapidly spread to different continents,
causing severe financial losses in the common carp and koi culture industries worldwide [9]. In
addition to its negative economical and societal impacts, CyHV-3 also has a negative environ-
mental impact by affecting wild carp populations [61,62]. Thus, CyHV-3 rapidly became the
subject of applied research aiming to develop diagnostic methods and a safe/efficacious vac-
cine. In the present study, we used BAC cloning mutagenesis and IVIS technology to develop
and characterize the first rationally designed attenuated recombinant CyHV-3 vaccine compat-
ible with mass vaccination. In addition, the present study demonstrated the importance of the
CyHV-3 - carp model as an interesting and original fundamental subject of research. This
model allows the study of the complete infectious cycle (including transmission from infected
to naïve animals) of an alloherpesvirus by infection of its natural host. Furthermore, infection
of carp by CyHV-3 represents a unique model for studying skin mucosal immunity in teleosts
in response to a natural infection.
Materials and Methods
Cells and viruses
CCB cells [63] were cultured in minimum essential medium (Sigma) containing 4.5 g/L glucose
(D-glucose monohydrate; Merck) and 10% fetal calf serum (FCS) as described previously [24].
The CyHV-3 FL strain was isolated from the kidney of a fish that died from CyHV-3 infection
and previously used to produce the FL BAC plasmid [24]. The FL BAC revertant ORF136 Luc
strain (called WT Luc in the present study) of CyHV-3 was derived from the FL BAC plasmid
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by prokaryotic mutagenesis [33]. The Cavoy strain was cultured from the Cavoy vaccine
(Novartis).
Fish
Common carp (Cyprinus carpio carpio) were kept in 60 L tanks at 24°C. Water parameters
were checked twice per week. Microbiological, parasitic, and clinical examinations of the fish
just before the experiments demonstrated that they were healthy. All experiments were preced-
ed by an acclimation period of at least 2 weeks.
Inoculation of fish with CyHV-3
Two modes of inoculation were used: inoculation by immersion in infectious water and inocu-
lation by cohabitation with newly infected fish. Fish were inoculated by immersion in water
(volume adapted based on fish size and fish number to use a biomass around 10%) containing
the virus for 2 h under constant aeration. At the end of the incubation period, the fish were re-
turned to 60 L tanks. For inoculation by cohabitation, newly infected fish were produced by im-
mersion of naïve fish for 2 h in water containing 200 pfu/ml of the FL strain. At the end of the
incubation period, newly infected fish were released into the tank of fish to be contaminated at
a ratio of 2 newly infected fish per 15 fish to be contaminated.
Ethics statement
The experiments, maintenance and care of fish complied with the guidelines of the European
Convention for the Protection of Vertebrate Animals used for Experimental and other Scientif-
ic Purposes (CETS n° 123). The animal studies were approved by the local ethics committee of
the University of Liège, Belgium (Laboratory accreditation No. 1610008, protocol No. 1059).
All efforts were made to minimize suffering.
Production of CyHV-3 recombinant strains using BAC cloning and
prokaryotic recombination technologies
Different recombinant BAC plasmids were produced using the FL BAC [24] and FL BAC
ORF134 Del plasmids [31] as parental plasmids (Fig. 1B). Recombinant plasmids were pro-
duced based on the strategy described in Fig. 1B using galK positive/negative selection in bacte-
ria as described previously [64]. Recombination cassettes encoding galK were produced by
PCR using the primers listed in Table 1 and the pgalK vector as the template. The ORF56-57
Del cassette consisted of 250 bp upstream (coordinates 96751-97000) and 249 bp downstream
(coordinates 99751-100000 with deletion of base 99760) of the ORF56-57 deletion (Fig. 1A,
ORF56-57 deletion). To reconstitute the infectious virus, the recombinant BAC plasmids were
co-transfected in CCB cells using polyethylenimine (3 μg polyethylenimine per 1 μg DNA)
with either the pGEMT-TK plasmid or pEFIN3 NLS Cre (molecular ratio 1:75) [24]. Transfec-
tion with pGEMT-TK plasmid induced recombination upstream and downstream of the BAC
cassette, leading to its complete removal and consequent reversion to a wild-type TK locus (FL
BAC revertant strains). Transfection with pEFIN3 NLS Cre induced expression of a nuclear
Cre recombinase and cre-loxP-mediated excision of the BAC cassette. Viruses reconstituted
(FL BAC excised strains) by this procedure express a truncated form of TK due to a 172 bp
foreign sequence of the BAC cassette left in the ORF55 locus. Independent of the method,
EGFP-negative plaques (the BAC cassette encodes an EGFP expression cassette) were picked
and amplified.
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Table 1. Primers used in this study.
Primer
name
Sequence (5’- 3’) Coordinates*/
Accession
number
Synthesis of probes for Southern blot analysis
Probe name
CyHV-3
ORF55
ORF55InF AGCGCTACACCGAAGAGTCC 95990–96009
ORF55stopR TCACAGGATAGATATGTTACAAG 96516–96494
CyHV-3
ORF 56–57
Del
ORF56–
57Pr5F
GGTACAAGACGGCCTGCTG 97247–97265
ORF56–
57Pr9R
GCCAGCACGTAGAGCTTGTG 99686–99667
CyHV-3
ORF134
Del
ORF134InF GGTTTCTCTTTGTAGTTTTCCG 229362–
229383
ORF134InR CACCCCAACTTTTGAGACAAC 229795–
229765
CyHV-3
ORF136–
137
ORF136F2 ATGAAGGCCTCTAAACTGCTG 231339–
231359
ORF137R2 ATGGACAGCACAAACGTTAC 233804–
233823
Luc LUCF3 TTGTGGATCTGGATACCGGG
LUCR3 GACACCTGCGTCGAAGATGT
qPCR analysis
Gene ampliﬁed
CyHV-3
ORF89
KHV-86F GACGCCGGAGACCTTGTG AF411803
KHV-163R CGGGTTCTTATTTTTGTCCTTGTT
KHV-109P (6FAM) CTTCCTCTGCTCGGCGAGCACG (BHQ1)
Carp
glucokinase
CgGluc-
162F
ACTGCGAGTGGAGACACATGAT AF053332
CgGluc-
230R
TCAGGTGTGGAGCGGACAT
CgGluc-
185P
(6FAM) AAGCCAGTGTCAAAATGCTGCCCACT (BHQ1)
Synthesis of recombination cassettes
Cassette name
ORF 134
Del galK
ORF134
galK F
ATGTTCCTTGCAGTGCTACTAACCGCGACCATCTTCTTCGAGGCTCGGGGCCTGTTGACAATTAATCATCGGCA 229791–
229840
ORF134
galK R
TCAATGTTTGCGCTTGGTTTTCATGTTCTTGACGTCTTTTGCGACCAGGATCAGCACTGTCCTGCTCCTT 229217–
229266
ORF 56–57
Del galK
ORF56–57
galK F
GTCCCTCGACAGCCCCAGCCCGCACAGCAGTCGCCACTCTTCCCTGTTGATCAGCACTGTCCTGCTCCTT 96951–97000
ORF56–57
galK R
AACCCGTACACGACGCGCTCAAGCAGCTTGATCTTGACGACGTCGTGCACCCTGTTGACAATTAATCATCGGCA 99800–99751
*Coordinates based on the reference CyHV-3 genome (GenBank accession number: NC_009127.1)
Underlined: 50 bp corresponding to the CyHV-3 sequence
Italic: sequence corresponding to galK
doi:10.1371/journal.ppat.1004690.t001
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Production of the Δ56-57 Luc strain by recombination in eukaryotic cells
The Δ56-57 Luc strain was produced by co-infection of CCB cells with two parental strains (S3
Fig.). CCB cells were superinfected at the MOI of 10 pfu/cell with the WT Luc strain and Δ56-
57 strain (ratio 1:1). When all cells expressed a cytopathic effect, the supernatant containing
progeny virions was collected and submitted to limiting dilution of clone virions. The recombi-
nant viral clone expressing both Luc and ORF56-57 deletion was selected by successive screen-
ing with the IVIS and PCR genotyping, respectively.
Production of antibodies raised against pORF56 and pORF57
Mouse polyclonal antibodies (pAb) directed against the unstructured domain (IUPred, http://
iupred.enzim.hu) of pORF56 encoded by coordinates 98049-99398 (GenBank accession num-
ber NC_009127.1) were produced by DNA immunization using a customized commercial ser-
vice (DelphiGenetics). Mouse monoclonal antibodies (mAb) directed against pORF57 were
selected from a bank of mAbs raised against CyHV-3 structural proteins; mAb 6B2 recognizes
an epitope expressed in the last 165 amino acid residues of pORF57 (genomic coordinates
100309-100803, GenBank accession number NC_009127.1).
Indirect immunofluorescence staining
Cells were fixed in PBS containing 4% (w/v) paraformaldehyde at 4°C for 15 min and then
20°C for 30 min. After washing with PBS, samples were permeabilized in PBS containing 0.1%
(v/v) NP-40 at 37°C for 15 min. Immunofluorescent staining (incubation and washes) was per-
formed in PBS containing 10% FCS (v/v). Mouse pAb raised against pORF56 (diluted 1:500),
mAb 6B2 raised against pORF57 (diluted 1:2500), and rabbit pAb raised against CyHV-3
structural proteins (diluted 1:1500) were used as the primary antibodies. The primary antibody
was incubated at 37°C for 1 h. Alexa Fluor 488 goat anti-mouse immunoglobulin G (H+L) and
Alexa Fluor 568 goat anti-rabbit immunoglobulin G (H+L) (Invitrogen) were used as the sec-
ondary antibodies. The secondary antibody was incubated at 37°C for 30 min. After washing,
cells were mounted using Prolong Gold Antifade Reagent with DAPI (Invitrogen).
Genetic characterization of CyHV-3 recombinants
CyHV-3 recombinants were characterized by RFLP using SacI digestion, Southern blot analy-
ses [31,33], sequencing of regions of interest (ROIs), and for some recombinants, full-length
genome sequencing. For full-length genome sequencing, DNA (500 ng) was sheared by sonica-
tion to an average size of 400 bp and prepared for sequencing using a KAPA library prepara-
tion kit (KAPA Biosystems, Woburn, MA, USA). The fragments were A-tailed, ligated to the
NEBnext Illumina adaptor (New England Biolabs, Ipswich, MA, USA), and amplified by PCR.
Index tags were added by six cycles of PCR using KAPA HiFi HotStart and NEBnext indexing
primers. The samples were analyzed using a MiSeq DNA sequencer running v2 chemistry (Illu-
mina, San Diego, CA, USA). Approximately 1 million 250-nucleotide paired-end reads were
obtained per sample. The reads were prepared for assembly using Trim Galore v. 0.2.2 (http://
www.bioinformatics.babraham.ac.uk/projects/trim_galore). A scaffold was assembled de novo
for the WT Luc strain using AbySS [65] and finished by referencing GenBank accession num-
ber NC_009127.1. Sequence accuracy was checked by assembling the reads against this se-
quence using BWA v. 0.6.2-r126 [66] and visualizing the alignment using Tablet v. 1.13.08.05
[67]. The other sequences were obtained by assembling the relevant reads against conceptual
modifications of the sequence of the WT Luc strain using BWA and checking it using Tablet.
In all viral genomes, two regions were of undetermined length: an A repeat and a GA repeat
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located at 32540–32465 and 177568-177730 nt, respectively, in NC_009127.1. The full length
genome sequence of the WT Luc and Δ56-57 Luc strains were deposited in the GenBank (Ac-
cession numbers KP343683 and KP343684, respectively).
Multi-step growth curves
Triplicate cultures of CCB cells were infected at a MOI of 0.1 pfu/cell. After an incubation peri-
od of 2 h, cells were washed with PBS and overlaid with Dulbecco’s modified essential medium
(DMEM, Sigma) containing 4.5 g of glucose/L and 10% FCS. Supernatant was removed from
the infected cultures at successive intervals (0, 2, 4, and 6 dpi) and stored at-80°C. The titration
of infectious viral particles was determined by duplicate plaque assays in CCB cells as described
previously [31,33].
In vivo bioluminescent imaging
Firefly (Photinus pyralis) luciferase was imaged using an IVIS (IVIS spectrum, Caliper Life-
Sciences) as described previously [33–35]. For cell culture analysis, the culture medium was re-
placed with fresh medium containing D-luciferin (150 μg/ml) (Caliper LifeSciences). Analyses
were performed after an incubation period of 5 min at room temperature. For in vivo analyses,
fish were anesthetized with benzocaine (25 mg/L of water). Fifteen minutes before biolumines-
cence analysis, D-luciferin (150 mg/kg of body weight) was injected into the peritoneal cavity.
After 15 minutes, the fish were analyzed in vivo lying on their right and left sides and ex vivo
after euthanasia. Dissected organs were analyzed independent from the body. All images pre-
sented in this study were acquired using a field view of C or D, a maximum auto-exposure time
of 1 minute, a binning factor of 4, and a f/stop of 1. The relative intensities of transmitted light
from bioluminescence and scales were determined automatically and represented as a pseudo-
color image ranging from violet (least intense) to red (most intense) using Living Image 3.2
software. ROIs were drawn manually by surrounding the organs or body outline, and the aver-
age radiance (p/sec/cm2/sr) was taken as the final measure of the bioluminescence emitted over
the ROI.
Quantification of virus genome copies in organs by real-time TaqMan
PCR
The virus genome was quantified by real-time TaqMan PCR as described previously [31], by
amplifying fragments of the CyHV-3 ORF89 and carp glucokinase genes. The primers and
probes are listed in Table 1.
Histopathological analysis of gills
Gills were dissected immediately after euthanasia and fixed in 4% buffered formalin before
embedding in paraffin [31]. Five-micrometer sections were stained with hematoxylin and
eosin, mounted, and examined by microscopy. Three independent observers scored the lesions
in a blind test mode using a 4-step scale. For each sample, a score was attributed for the gill rak-
ers and gill lamellae. When at least two observers agreed on a grade, the corresponding grade
was attributed. In a few exceptional cases, when all three examiners scored differently, addi-
tional analyses were performed until achieving a majority. The grading system evaluated the
degree of epithelial hyperplasia, the presence of intra-nuclear viral inclusions, and cell degener-
ation (Fig. 7A). Briefly, grade 0 = physiological state; grade 1 = mild hyperplasia without evi-
dence of degenerated cells and viral inclusions; grade 2 = severe hyperplasia and presence of
few degenerated cells and viral inclusions; and grade 3 = the presence of abundant degenerated
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cells and viral inclusions (gill lamellae and gill rakers), massive epithelial hyperplasia filling the
entire secondary lamellae inter-space (gill lamellae), and ulcerative erosion of the epithelium
(gill rakers).
Statistical analysis
The number of positive fish or positive organs (qualitative data) according to the two viral
strains was compared by a permutation test (Figs. 5–8). Briefly, all occurrences were recorded
in a dataset (observed dataset). A series of 10,000 random repetitions of the same procedure
was performed to allocate positive events to the two groups, creating the shuffled datasets. For
each dataset (observed dataset and shuffled datasets), the global difference between the two
groups was calculated by summing the daily observed differences. The proportion of shuffled
datasets with a global difference greater or equal to the global difference in the observed dataset
was then taken as the p-value. Histopathological grading results were compared by a permuta-
tion test after calculating the value per group and per day corresponding to the sum of all indi-
vidual grades obtained in each group (Fig. 7). Viral growth (Fig. 3A), IVIS (Figs. 3B, 5, and 9B),
and qPCR results (Fig. 6) were compared as quantitative data (level of positivity) using two- or
three-way ANOVA with interactions followed by post-hoc t-test. The variables used and com-
parisons retained for statistical illustrations are described in their respective figure legends.
Presence or absence of statistical significance is represented as follows, ns: not significant,
 p<0.05,  p<0.01,  p<0.001.
Supporting Information
S1 Fig. Structural analysis of double Δ56-57 and triple Δ56-57Δ134 deleted recombinants.
The indicated strains were analyzed by SacI restriction (left) and Southern blotting using
ORF55, ORF56-57 Del, and ORF134 Del probes. Black and white arrowheads indicate frag-
ments containing ORF134 and ORF56-57, respectively. Markers sizes (MS) are indicated on
the left.
(TIF)
S2 Fig. Safety-efficacy profile of double Δ56-57 and triple Δ56-57Δ134 deleted recombi-
nants encoding a truncated TK locus. The safety and efficacy of the indicated recombinant
strains was tested in common carp (average weight 4.41 g ± 1.78 g, 7 months old). On day 0,
fish were infected for 2 h by immersion in water containing 4 (□), 40 (), or 400 (x) pfu/ml.
Safety was investigated by measuring the survival rate for 21 days in a group of 30 carp. Efficacy
was tested at 21 and 42 dppi. Mock-infected fish and fish that survived the primary infection
were distributed in tanks (n = 15) and challenged by cohabitation with fish infected with the
FL strain.
(TIF)
S3 Fig. Production of a recombinant Δ56-57 strain expressing Luciferase. (A) Molecular
structure of the Δ56-57 strain andWT Luc strain used as parental strains for production of the
Δ56-57 Luc strain by co-infection in eukaryotic cells. ORFs are represented by white or grey ar-
rows, the Luc cassette by a grey rectangle, and CyHV-3 terminal repeats by white rectangles.
The positions of SacI restriction sites and restriction fragment lengths are shown below each
genotype. (B) Schematic representation of the method used to produce recombinant strains by
co-infection of two parental strains. The molecular structures of the four possible recombinant
strains resulting from unique or multiple cross-overs are illustrated.
(TIF)
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S4 Fig. Structure analysis of the Δ56-57 Luc strain. The indicated strains were analyzed by
SacI restriction (left) and Southern blotting using ORF55, ORF56-57 Del, ORF136-137, and
Luc probes. White and white-outlined black arrowheads indicate fragments containing
ORF56-57 loci and ORF136-137 loci, respectively. Black arrowheads indicate the restriction
fragment containing most of the Luc cassette sequence. Marker sizes (MS) are indicated on
the left.
(TIF)
S5 Fig. pORF56 and pORF57 expression by the Cavoy strain of CyHV-3. CCB cells were in-
fected with the indicated strains. One day post-infection, cells were treated for indirect immu-
nofluorescent staining and confocal microscopic analysis of pORF56 or pORF57 (green),
CyHV-3 structural proteins (red), and cell nuclei (blue). The overlay represents the superposi-
tion of the three channels. White scale bars = 20 μm.
(TIF)
S1 Dataset. Raw data of the experiments presented in Fig. 3.
(XLSX)
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